Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (250)

2024

  1. ApTOLL: A new therapeutic aptamer for cytoprotection and (re)myelination after multiple sclerosis

    British Journal of Pharmacology, Vol. 181, Núm. 17, pp. 3263-3281

2023

  1. Aging, NRF2, and TAU: A Perfect Match for Neurodegeneration?

    Antioxidants, Vol. 12, Núm. 8

  2. Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction

    Biomedicine and Pharmacotherapy, Vol. 158

  3. Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43

    Nature Communications, Vol. 14, Núm. 1

  4. Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  5. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

    Nature Communications, Vol. 14, Núm. 1

  6. Ludificación y mentoría en Ingeniería Genética: construcción de unjuego docente sobre la infraestructura LAMP

    II Jornada «Aprendizaje Eficaz con TIC en la UCM» (Ediciones Complutense), pp. 41-52

  7. Neighborhood Vulnerability and Disability in First Episode of Psychosis: A Multilevel Study

    The Journal of clinical psychiatry, Vol. 84, Núm. 2

  8. Neutrophil β1 adrenoceptor blockade blunts stroke-associated neuroinflammation

    British Journal of Pharmacology, Vol. 180, Núm. 4, pp. 459-478

2022

  1. A Dual Role for FADD in Human Precursor T-Cell Neoplasms

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

  2. Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis

    Journal of Medicinal Chemistry, Vol. 65, Núm. 3, pp. 1867-1882

  3. New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

    Biomolecules, Vol. 12, Núm. 9

  4. The relationship between negative symptoms, social cognition, and social functioning in patients with first episode psychosis

    Journal of Psychiatric Research, Vol. 155, pp. 171-179

2021

  1. Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration

    Acta Neuropathologica Communications, Vol. 9, Núm. 1

  2. Central activation of alpha7 nicotinic signaling attenuates lps-induced neuroinflammation and sickness behavior in adult but not in aged animals

    Molecules, Vol. 26, Núm. 8

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. IGF-1 facilitates extinction of conditioned fear

    eLife, Vol. 10

  5. Molecular alterations in sporadic and sod1-als immortalized lymphocytes: Towards a personalized therapy

    International Journal of Molecular Sciences, Vol. 22, Núm. 6, pp. 1-17

  6. Monoaminergic system and antidepressants

    The Neuroscience of Depression: Features, Diagnosis, and Treatment (Elsevier), pp. 345-355

  7. Monoaminergic system and antidepressants

    The Neuroscience of Depression, 1st Edition: Volume 1-2 (Elsevier), pp. V1-345-V1-355